FCM
PBYI icon

Frontier Capital Management’s Puma Biotechnology PBYI Stock Holding History

Frontier Capital Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-11,755
Closed -$886K – 363
2015
Q3 		$886K Sell
11,755
-1,416
-11% -$134K 0.01% 315
2015
Q2 		$1.54M Sell
13,171
-13,612
-51% -$2.47M 0.01% 317
2015
Q1 		$6.32M Sell
26,783
-31,106
-54% -$6.65M 0.05% 285
2014
Q4 		$11M Sell
57,889
-151,741
-72% -$33.7M 0.08% 253
2014
Q3 		$50M Buy
+209,630
New +$43M 0.4% 83

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Frontier Capital Management's PBYI Position: Q4 2015 in Review

Frontier Capital Management sold out of Puma Biotechnology (PBYI) in Q4 2015, closing a stake of 11,755 shares — an estimated $886K sold.

Frontier Capital Management first reported a position in PBYI in Q3 2014 and held it in 5 quarters. The position peaked at $50M in Q3 2014. 133 funds tracked by Wall St. Rank hold PBYI as of Q4 2015.

  • Frontier Capital Management reported no remaining Puma Biotechnology position as of Q4 2015 after selling out during the quarter.
  • Frontier Capital Management sold 11,755 Puma Biotechnology shares in Q4 2015, an estimated $886K.
  • Frontier Capital Management first reported a position in Puma Biotechnology in Q3 2014 and held it in 5 quarters.
  • Frontier Capital Management's Puma Biotechnology position peaked at $50M in Q3 2014.
  • 133 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2015.

Based on Frontier Capital Management's 13F filing for Q4 2015, filed 27 Jan 2016.